drugset / Trial / NCT01510912

Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain

NCT01510912

Phase 3 Completed 602 enrolled Iroko Pharmaceuticals, LLC
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the safety of Diclofenac \[Test\] Capsules for the treatment of osteoarthritis pain of the knee or hip.

Timeline

Start
2012-01
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 35 mg

Indications